These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27351633)

  • 1. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicology is IN: in silico, in vitro, integrated testing strategy.
    Caloni F; Benfenati E; Sambuy Y
    ALTEX; 2016; 33(2):187-8. PubMed ID: 27032091
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicology and stem cells: New frontiers.
    Caloni F; Ferrari M; De Angelis I
    ALTEX; 2014; 31(1):94. PubMed ID: 24448761
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R; Burkhardt J; Kadambi VJ
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterising hepatic mitochondrial function as a model for systemic toxicity: a commentary.
    Leach AR; Wallace K; Alepee N; Daston G; Humphris C; Manou I; Modi S; Ringeissen S; Whelan M; Kimber I
    Toxicology; 2012 Dec; 302(1):96-9. PubMed ID: 23126011
    [No Abstract]   [Full Text] [Related]  

  • 8. Call to curb lab tests on dogs.
    Turner M
    Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to: Bayesian network integrated testing strategy and beyond.
    Jaworska J
    ALTEX; 2013; 30(3):391. PubMed ID: 23861082
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Prueitt RL; Beck BD
    Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Waddell WJ
    Hum Exp Toxicol; 2010 Jan; 29(1):31-2. PubMed ID: 20061465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
    Yoon M; Blaauboer BJ; Clewell HJ
    Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
    Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of stem cells as alternative methods to animal experimentation in predictive toxicology.
    Kim TW; Che JH; Yun JW
    Regul Toxicol Pharmacol; 2019 Jul; 105():15-29. PubMed ID: 30930176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.